Grants & FundingHealthcareDefense & MilitaryMedical CountermeasuresBurn CarePharmaceutical DevelopmentAward
3 days agoDoW Adds $3.3 Million to MediWound’s NexoBrid Development Program
The U.S. Department of War added $3.3 million for a room-temperature-stable NexoBrid formulation intended for battlefield burn care, bringing the program budget to $21.8 million. Separately, BARDA-related purchases through Vericel’s contract are expected to continue through Q1 2027; neither activity represents a newly announced solicitation.